Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.550
+0.030 (1.97%)
Sep 5, 2025, 4:00 PM - Market closed

Company Description

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally.

The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform.

The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022.

Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

Intelligent Bio Solutions Inc.
Intelligent Bio Solutions logo
CountryUnited States
Founded2016
IndustryMedical Devices
SectorHealthcare
Employees55
CEOHarry Simeonidis

Contact Details

Address:
135 West, 41st Street, 5th Floor
New York, New York 10036
United States
Phone646 828 8258
Websiteibs.inc

Stock Details

Ticker SymbolINBS
ExchangeNASDAQ
Fiscal YearJuly - June
Reporting CurrencyUSD
CIK Code0001725430
CUSIP Number36151G600
ISIN NumberUS36151G6008
Employer ID82-1512711
SIC Code3841

Key Executives

NamePosition
Harry SimeonidisPresident and Chief Executive Officer
Spiro Kevin Sakiris B.Bus, C.A., CA, Dip LawChief Financial Officer
Callistus SequeiraVice President of Global Quality and Operations
Doug HeathVice President of Global Sales
Anna TurkingtonVice President of Marketing

Latest SEC Filings

DateTypeTitle
Aug 25, 2025S-3/A[Amend] Registration statement under Securities Act of 1933
Aug 22, 2025S-3Registration statement under Securities Act of 1933
Aug 15, 20258-KCurrent Report
Aug 15, 202510-KAnnual Report
Aug 11, 2025DNotice of Exempt Offering of Securities
Aug 7, 20258-KCurrent Report
Aug 6, 20258-KCurrent Report
Jul 28, 20258-KCurrent Report
Jul 23, 20258-KCurrent Report
Jul 16, 20258-KCurrent Report